Heart Transplantation in Adriamycin-Associated Cardiomyopathy in the Contemporary Era of Advanced Heart Failure Therapies

BACKGROUND: Adriamycin-associated cardiomyopathy (ACM) can lead to end-stage heart failure requiring advanced heart failure therapies. OBJECTIVES: This study sought to provide post–cardiac transplant survival data in patients with ACM in the contemporary era of mechanical circulatory support and car...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramu, Bhavadharini, Masotti, Maria, Tedford, Ryan J., Cogswell, Rebecca J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352281/
https://www.ncbi.nlm.nih.gov/pubmed/34396337
http://dx.doi.org/10.1016/j.jaccao.2021.02.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352281/
https://www.ncbi.nlm.nih.gov/pubmed/34396337
http://dx.doi.org/10.1016/j.jaccao.2021.02.010

Ejemplares similares